<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.44889.016</object-id><label>Table 1.</label><caption><title>List of the 41 hit compounds that rescued the expression of both <italic>vcanb</italic> and <italic>mbp</italic> in <italic>adgrg6<sup>tb233c</sup></italic> mutants, thus representing putative Adgrg6 pathway modulators.</title><p>The table includes the plate and well ID, along with known activities and the average score from nine <italic>adgrg6<sup>tb233c</sup></italic> embryos in the <italic>vcanb</italic> assay, from six <italic>adgrg6<sup>tb233c</sup></italic> embryos in the <italic>mbp</italic> assay and from three <italic>adgrg6<sup>fr24</sup></italic> embryos in the <italic>fr24</italic> assay. Grey shading indicates compounds presumed to interact with Adgrg6 receptor directly; yellow shading indicates compounds presumed to be downstream effectors of the pathway. Abbreviations: DE, dead embryos; ND, no data; S, Spectrum; T, Tocris. *Note that cilnidipine can rescue <italic>fr24</italic> at 40 &#181;M (data not shown).&#160;See&#160;also&#160;<xref ref-type="supplementary-material" rid="table1sdata1">Table 1&#8212;source data 1</xref>.</p><p><supplementary-material id="table1sdata1"><object-id pub-id-type="doi">10.7554/eLife.44889.017</object-id><label>Table 1&#8212;source data 1.</label><caption><title>Source data for <xref ref-type="table" rid="table1">Table 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-44889-table1-data1-v2.xlsx"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th>#</th><th>Plate</th><th>Well</th><th>Compound name</th><th>Known activity</th><th><italic>vcanb</italic> score</th><th><italic>mbp</italic> score</th><th><italic>fr24</italic> score</th></tr></thead><tbody><tr><td style="author-callout-style-b8">1</td><td style="author-callout-style-b8">S18</td><td style="author-callout-style-b8">C09</td><td style="author-callout-style-b8">CARAPIN-8(9)-ENE</td><td style="author-callout-style-b8">undetermined</td><td style="author-callout-style-b8">0.00</td><td style="author-callout-style-b8">8.50</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">2</td><td style="author-callout-style-b8">S25</td><td style="author-callout-style-b8">D08</td><td style="author-callout-style-b8">3-ISOBUTYL-1-METHYLXANTHINE (IBMX)</td><td style="author-callout-style-b8">phosphodiesterase inhibitor, non-selective adenosine receptor antagonist</td><td style="author-callout-style-b8">2.00</td><td style="author-callout-style-b8">8.50</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">3</td><td style="author-callout-style-b8">S17</td><td style="author-callout-style-b8">F05</td><td style="author-callout-style-b8">DEOXYGEDUNIN</td><td style="author-callout-style-b8">neuroprotective</td><td style="author-callout-style-b8">2.00</td><td style="author-callout-style-b8">8.00</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">4</td><td style="author-callout-style-b8">S23</td><td style="author-callout-style-b8">F10</td><td style="author-callout-style-b8">DIHYDROFISSINOLIDE</td><td style="author-callout-style-b8">undetermined</td><td style="author-callout-style-b8">2.67</td><td style="author-callout-style-b8">7.50</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">5</td><td style="author-callout-style-b8">S04</td><td style="author-callout-style-b8">B02</td><td style="author-callout-style-b8">IVERMECTIN</td><td style="author-callout-style-b8">antiparasitic</td><td style="author-callout-style-b8">2.33</td><td style="author-callout-style-b8">7.00</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">6</td><td style="author-callout-style-b8">T01</td><td style="author-callout-style-b8">F06</td><td style="author-callout-style-b8">SC-10</td><td style="author-callout-style-b8">protein kinase C activator, NMDA receptor activator</td><td style="author-callout-style-b8">5.67</td><td style="author-callout-style-b8">6.50</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">7</td><td style="author-callout-style-b8">T01</td><td style="author-callout-style-b8">H11</td><td style="author-callout-style-b8">1,3-Dipropyl-8-phenylxanthine</td><td style="author-callout-style-b8">Selective adenosine A1 receptor antagonist</td><td style="author-callout-style-b8">3.33</td><td style="author-callout-style-b8">6.50</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">8</td><td style="author-callout-style-b8">S17</td><td style="author-callout-style-b8">E02</td><td style="author-callout-style-b8">3-DEOXO-3beta-ACETOXYDEOXYDIHYDROGEDUNIN</td><td style="author-callout-style-b8">undetermined</td><td style="author-callout-style-b8">0.00</td><td style="author-callout-style-b8">6.50</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">9</td><td style="author-callout-style-b8">T11</td><td style="author-callout-style-b8">F07</td><td style="author-callout-style-b8">Cilnidipine*</td><td style="author-callout-style-b8">dihydropyridine N- and L-type Ca<sup>2+</sup> channel blocker</td><td style="author-callout-style-b8">2.00</td><td style="author-callout-style-b8">6.50</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">10</td><td style="author-callout-style-b8">S13</td><td style="author-callout-style-b8">F03</td><td style="author-callout-style-b8">AMIODARONE HYDROCHLORIDE</td><td style="author-callout-style-b8">coronary vasodilator, Ca<sup>2+</sup> channel blocker</td><td style="author-callout-style-b8">5.00</td><td style="author-callout-style-b8">6.50</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">11</td><td style="author-callout-style-b8">S06</td><td style="author-callout-style-b8">E02</td><td style="author-callout-style-b8">HYDROCORTISONE HEMISUCCINATE</td><td style="author-callout-style-b8">glucocorticoid</td><td style="author-callout-style-b8">3.67</td><td style="author-callout-style-b8">6.00</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">12</td><td style="author-callout-style-b8">T01</td><td style="author-callout-style-b8">C04</td><td style="author-callout-style-b8">(RS)-(Tetrazol-5-yl)glycine</td><td style="author-callout-style-b8">highly potent NMDA receptor agonist</td><td style="author-callout-style-b8">3.00</td><td style="author-callout-style-b8">5.00</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">13</td><td style="author-callout-style-b8">S02</td><td style="author-callout-style-b8">E05</td><td style="author-callout-style-b8">LOMEFLOXACIN HYDROCHLORIDE</td><td style="author-callout-style-b8">antibacterial</td><td style="author-callout-style-b8">5.33</td><td style="author-callout-style-b8">5.00</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">14</td><td style="author-callout-style-b8">S13</td><td style="author-callout-style-b8">E04</td><td style="author-callout-style-b8">ETHAMIVAN</td><td style="author-callout-style-b8">CNS &amp; respiratory stimulant</td><td style="author-callout-style-b8">4.67</td><td style="author-callout-style-b8">5.00</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">15</td><td style="author-callout-style-b8">T08</td><td style="author-callout-style-b8">B04</td><td style="author-callout-style-b8">CGS 15943</td><td style="author-callout-style-b8">potent adenosine receptor antagonist</td><td style="author-callout-style-b8">5.33</td><td style="author-callout-style-b8">4.50</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">16</td><td style="author-callout-style-b8">S13</td><td style="author-callout-style-b8">E09</td><td style="author-callout-style-b8">ASTEMIZOLE</td><td style="author-callout-style-b8">H1 antihistamine (nonsedating)</td><td style="author-callout-style-b8">4.67</td><td style="author-callout-style-b8">4.50</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">17</td><td style="author-callout-style-b8">T02</td><td style="author-callout-style-b8">A09</td><td style="author-callout-style-b8">SKF 91488 dihydrochloride</td><td style="author-callout-style-b8">histamine N-methyltransferase inhibitor</td><td style="author-callout-style-b8">3.00</td><td style="author-callout-style-b8">4.00</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">18</td><td style="author-callout-style-b8">S25</td><td style="author-callout-style-b8">F05</td><td style="author-callout-style-b8">11alpha-HYDROXYPROGESTERONE HEMISUCCINATE</td><td style="author-callout-style-b8">glucocorticoid</td><td style="author-callout-style-b8">2.67</td><td style="author-callout-style-b8">4.00</td><td style="author-callout-style-b8">9.00</td></tr><tr><td style="author-callout-style-b8">19</td><td style="author-callout-style-b8">T14</td><td style="author-callout-style-b8">A07</td><td style="author-callout-style-b8">Efonidipine hydrochloride monoethanolate</td><td style="author-callout-style-b8">dihydropyridine L-type and T-type Ca<sup>2+</sup> channel blocker</td><td style="author-callout-style-b8">3.67</td><td style="author-callout-style-b8">4.00</td><td style="author-callout-style-b8">9.00</td></tr><tr><td>20</td><td>T05</td><td>C09</td><td>Nifedipine</td><td>dihydropyridine L-type Ca<sup>2+</sup> channel blocker</td><td>4.33</td><td>7.00</td><td>8.00</td></tr><tr><td>21</td><td>T05</td><td>E08</td><td>CGP 37157</td><td>antagonist of mitochondrial Na<sup>+</sup>/Ca<sup>2+</sup> exchange</td><td>3.67</td><td>6.50</td><td>8.00</td></tr><tr><td>22</td><td>S05</td><td>D03</td><td>DANAZOL</td><td>anterior pituitary suppressant, anti-estrogenic</td><td>1.00</td><td>5.00</td><td>8.00</td></tr><tr><td>23</td><td>S18</td><td>H09</td><td>XANTHYLETIN</td><td>undetermined</td><td>1.00</td><td>4.50</td><td>8.00</td></tr><tr><td>24</td><td>S18</td><td>A06</td><td>FERULIC ACID</td><td>antineoplastic, choleretic, food preservative</td><td>3.67</td><td>4.00</td><td>8.00</td></tr><tr><td>25</td><td>S18</td><td>F02</td><td>alpha-DIHYDROGEDUNOL</td><td>undetermined</td><td>2.33</td><td>4.00</td><td>8.00</td></tr><tr><td style="author-callout-style-b4">26</td><td style="author-callout-style-b4">T05</td><td style="author-callout-style-b4">F04</td><td style="author-callout-style-b4">(S)-(+)-Niguldipine hydrochloride</td><td style="author-callout-style-b4">dihydropyridine L-type Ca<sup>2+</sup> channel blocker, &#945;1 antagonist</td><td style="author-callout-style-b4">3.67</td><td style="author-callout-style-b4">5.00</td><td style="author-callout-style-b4">7.00</td></tr><tr><td style="author-callout-style-b4">27</td><td style="author-callout-style-b4">T07</td><td style="author-callout-style-b4">F02</td><td style="author-callout-style-b4">Tracazolate hydrochloride</td><td style="author-callout-style-b4">subtype-selective GABA<sub>A</sub>allosteric modulator</td><td style="author-callout-style-b4">2.33</td><td style="author-callout-style-b4">4.50</td><td style="author-callout-style-b4">7.00</td></tr><tr><td style="author-callout-style-b4">28</td><td style="author-callout-style-b4">S10</td><td style="author-callout-style-b4">E02</td><td style="author-callout-style-b4">NIMODIPINE</td><td style="author-callout-style-b4">dihydropyridine L-type Ca<sup>2+</sup> channel blocker</td><td style="author-callout-style-b4">0.33</td><td style="author-callout-style-b4">7.00</td><td style="author-callout-style-b4">6.00</td></tr><tr><td style="author-callout-style-b4">29</td><td style="author-callout-style-b4">S17</td><td style="author-callout-style-b4">E06</td><td style="author-callout-style-b4">3beta-ACETOXYDEOXODIHYDROGEDUNIN</td><td style="author-callout-style-b4">undetermined</td><td style="author-callout-style-b4">2.00</td><td style="author-callout-style-b4">4.50</td><td style="author-callout-style-b4">5.00</td></tr><tr><td style="author-callout-style-b4">30</td><td style="author-callout-style-b4">S17</td><td style="author-callout-style-b4">F02</td><td style="author-callout-style-b4">DIHYDROGEDUNIN</td><td style="author-callout-style-b4">undetermined</td><td style="author-callout-style-b4">1.67</td><td style="author-callout-style-b4">5.00</td><td style="author-callout-style-b4">2.00</td></tr><tr><td style="author-callout-style-b4">31</td><td style="author-callout-style-b4">S22</td><td style="author-callout-style-b4">F09</td><td style="author-callout-style-b4">TANGERITIN</td><td style="author-callout-style-b4">undetermined</td><td style="author-callout-style-b4">1.33</td><td style="author-callout-style-b4">5.50</td><td style="author-callout-style-b4">1.00</td></tr><tr><td style="author-callout-style-b4">32</td><td style="author-callout-style-b4">S10</td><td style="author-callout-style-b4">F07</td><td style="author-callout-style-b4">COLFORSIN</td><td style="author-callout-style-b4">adenylate cyclase activator, antiglaucoma, hypotensive, vasodilator</td><td style="author-callout-style-b4">0.00</td><td style="author-callout-style-b4">9.00</td><td style="author-callout-style-b4">0.00</td></tr><tr><td>33</td><td>T04</td><td>G02</td><td>Imiloxan hydrochloride</td><td>selective &#945;<sub>2B</sub>-adrenoceptor antagonist</td><td>0.67</td><td>9.00</td><td>ND</td></tr><tr><td>34</td><td>S24</td><td>C03</td><td>3alpha-ACETOXYDIHYDRODEOXYGEDUNIN</td><td>undetermined</td><td>0.33</td><td>8.50</td><td>DE</td></tr><tr><td style="author-callout-style-b4">35</td><td style="author-callout-style-b4">S11</td><td style="author-callout-style-b4">E02</td><td style="author-callout-style-b4">EZETIMIBE</td><td style="author-callout-style-b4">antihyperlipidemic (sterol absorption inhibitor)</td><td style="author-callout-style-b4">2.00</td><td style="author-callout-style-b4">7.50</td><td style="author-callout-style-b4">0.00</td></tr><tr><td>36</td><td>S10</td><td>E06</td><td>NITRENDIPINE</td><td>dihydropyridine L-type Ca<sup>2+</sup> channel blocker</td><td>1.33</td><td>7.00</td><td>ND</td></tr><tr><td style="author-callout-style-b4">37</td><td style="author-callout-style-b4">S11</td><td style="author-callout-style-b4">E08</td><td style="author-callout-style-b4">ROSUVASTATIN CALCIUM</td><td style="author-callout-style-b4">antihyperlipidemic</td><td style="author-callout-style-b4">0.00</td><td style="author-callout-style-b4">6.00</td><td style="author-callout-style-b4">0.00</td></tr><tr><td style="author-callout-style-b4">38</td><td style="author-callout-style-b4">S22</td><td style="author-callout-style-b4">C07</td><td style="author-callout-style-b4">DEMETHYLNOBILETIN</td><td style="author-callout-style-b4">undetermined</td><td style="author-callout-style-b4">0.00</td><td style="author-callout-style-b4">6.00</td><td style="author-callout-style-b4">0.00</td></tr><tr><td>39</td><td>S22</td><td>G11</td><td>HEXAMETHYLQUERCETAGETIN</td><td>undetermined</td><td>0.00</td><td>5.50</td><td>DE</td></tr><tr><td>40</td><td>S22</td><td>F08</td><td>NOBILETIN</td><td>matrix metaloproteinase inhibitor, antineoplastic, anti-ERK, NF-&#954;B suppressor</td><td>0.00</td><td>5.00</td><td>DE</td></tr><tr><td>41</td><td>S12</td><td>H07</td><td>PREGNENOLONE SUCCINATE</td><td>glucocortcoid, antiinflammatory</td><td>4.67</td><td>4.00</td><td>DE</td></tr></tbody></table></table-wrap>